HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pervasive Genomic Damage in Experimental Intracerebral Hemorrhage: Therapeutic Potential of a Mechanistic-Based Carbon Nanoparticle.

Abstract
Therapy for intracerebral hemorrhage (ICH) remains elusive, in part dependent on the severity of the hemorrhage itself as well as multiple deleterious effects of blood and its breakdown products such as hemin and free iron. While oxidative injury and genomic damage have been seen following ICH, the details of this injury and implications remain unclear. Here, we discovered that, while free iron produced mostly reactive oxygen species (ROS)-related single-strand DNA breaks, hemin unexpectedly induced rapid and persistent nuclear and mitochondrial double-strand breaks (DSBs) in neuronal and endothelial cell genomes and in mouse brains following experimental ICH comparable to that seen with γ radiation and DNA-complexing chemotherapies. Potentially as a result of persistent DSBs and the DNA damage response, hemin also resulted in senescence phenotype in cultured neurons and endothelial cells. Subsequent resistance to ferroptosis reported in other senescent cell types was also observed here in neurons. While antioxidant therapy prevented senescence, cells became sensitized to ferroptosis. To address both senescence and resistance to ferroptosis, we synthesized a modified, catalytic, and rapidly internalized carbon nanomaterial, poly(ethylene glycol)-conjugated hydrophilic carbon clusters (PEG-HCC) by covalently bonding the iron chelator, deferoxamine (DEF). This multifunctional nanoparticle, DEF-HCC-PEG, protected cells from both senescence and ferroptosis and restored nuclear and mitochondrial genome integrity in vitro and in vivo. We thus describe a potential molecular mechanism of hemin/iron-induced toxicity in ICH that involves a rapid induction of DSBs, senescence, and the consequent resistance to ferroptosis and provide a mechanistic-based combinatorial therapeutic strategy.
AuthorsPrakash Dharmalingam, Girish Talakatta, Joy Mitra, Haibo Wang, Paul J Derry, Lizanne Greer Nilewski, Emily A McHugh, Roderic H Fabian, Kimberly Mendoza, Velmarini Vasquez, Pavana M Hegde, Eugenia Kakadiaris, Trenton Roy, Istvan Boldogh, Venkatesh L Hegde, Sankar Mitra, James M Tour, Thomas A Kent, Muralidhar L Hegde
JournalACS nano (ACS Nano) Vol. 14 Issue 3 Pg. 2827-2846 (03 24 2020) ISSN: 1936-086X [Electronic] United States
PMID32049495 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Reactive Oxygen Species
  • Polyethylene Glycols
  • Hemin
  • Carbon
  • Iron
  • Deferoxamine
Topics
  • Animals
  • Carbon (pharmacology)
  • Cell Differentiation (drug effects)
  • Cells, Cultured
  • Cellular Senescence (drug effects)
  • Cerebral Hemorrhage (drug therapy, genetics, metabolism)
  • DNA Breaks, Single-Stranded (drug effects)
  • DNA Damage
  • Deferoxamine (pharmacology)
  • Hemin (antagonists & inhibitors, pharmacology)
  • Humans
  • Iron (pharmacology)
  • Mice
  • Mitochondria (drug effects)
  • Nanoparticles (chemistry)
  • Polyethylene Glycols (pharmacology)
  • Reactive Oxygen Species (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: